158 related articles for article (PubMed ID: 20863358)
1. Atypical case of Alzheimer's disease mimicking Creutzfeldt-Jakob disease: interest of cerebrospinal fluid biomarkers in the differential diagnosis.
Mahmoudi R; Manckoundia P; Morrone I; Lang PO; Dramé M; Novella JL
J Am Geriatr Soc; 2010 Sep; 58(9):1821-3. PubMed ID: 20863358
[No Abstract] [Full Text] [Related]
2. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
[TBL] [Abstract][Full Text] [Related]
3. Dementia, myoclonus, and EEG findings typical of Jakob-Creutzfeldt disease in a patient with Alzheimer's disease.
Katz PR; Chutkow JG
N Y State J Med; 1986 Mar; 86(3):157-8. PubMed ID: 3517711
[No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
Brunnström H; Rawshani N; Zetterberg H; Blennow K; Minthon L; Passant U; Englund E
Alzheimers Dement; 2010 Mar; 6(2):104-9. PubMed ID: 20298970
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Creutzfeldt-Jakob disease, Lewy body disease, and Alzheimer's disease pathology: an autopsy case showing typical clinical features of Creutzfeldt-Jakob disease.
Haraguchi T; Terada S; Ishizu H; Sakai K; Tanabe Y; Nagai T; Takata H; Nobukuni K; Ihara Y; Kitamoto T; Kuroda S
Neuropathology; 2009 Aug; 29(4):454-9. PubMed ID: 18715272
[TBL] [Abstract][Full Text] [Related]
7. [Myoclonus in Alzheimer's disease. 2 anatomoclinical cases].
Zarranz JJ; Burgos J; Madoz P; Larracoechea J; Forcadas I; Bilbao A
Acta Neurol Latinoam; 1979; 25(1-2):61-73. PubMed ID: 394558
[TBL] [Abstract][Full Text] [Related]
8. [A case of Alzheimer's disease simulating Creutzfeldt-Jakob disease].
Barcikowska M; Mirecka B; Papierz W; Bogucki M; Niewodniczy A; Liberski PP
Neurol Neurochir Pol; 1992; 26(5):703-10. PubMed ID: 1291909
[TBL] [Abstract][Full Text] [Related]
9. [Interesting not only as differential Alzheimer dementia diagnosis. Bovine spongiform encephalopathy and other prion diseases].
Kretzschmar H
MMW Fortschr Med; 2000 Sep; 142(39):34-8. PubMed ID: 11072695
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrospinal fluid neuron-specific enolase as a useful indicator for the early diagnosis of Creutzfeldt-Jakob disease].
Shibuya S; Wakayama Y; Jimi T
Rinsho Shinkeigaku; 1997 Jul; 37(7):656; author reply 657. PubMed ID: 9396368
[No Abstract] [Full Text] [Related]
12. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
[TBL] [Abstract][Full Text] [Related]
13. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
Holsinger RM; Lee JS; Boyd A; Masters CL; Collins SJ
Neurology; 2006 Aug; 67(4):710-2. PubMed ID: 16924032
[TBL] [Abstract][Full Text] [Related]
14. [Difficulties in differential diagnosis of long-term Creutzfeldt- Jakob disease].
López OL; Larumbe MR; Becker JT; Martínez-Lage JM; Boller F
Neurologia; 1995 Jan; 10(1):37-40. PubMed ID: 7893510
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
D'Ascenzo M; Relkin NR; Lee KH
Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease.
Otto M; Wiltfang J
Restor Neurol Neurosci; 2003; 21(3-4):191-209. PubMed ID: 14530581
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
[TBL] [Abstract][Full Text] [Related]
20. Early clinical and laboratory diagnosis of Creutzfeldt-Jakob disease.
Felgenhauer K; Weber T; Poser S
Dev Biol Stand; 1993; 80():125-30. PubMed ID: 8270102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
